Goodwin advised 1X Technologies on the funding round. 1X Technologies announced the closing of its $100 million Series B financing round that included participation from EQT...
You must be a Standard 1 Year member to access this content.
Goodwin advised Renesas Electronics Corporation on the acquisition of Transphorm, assisted by Wilson Sonsini Goodrich & Rosati. On January 11, 2024, Renesas Electronics Corporation (Renesas, TSE:...
You must be a Standard 1 Year member to access this content.
Evercore Group L.L.C. acted as financial advisor to Merck in this transaction and Covington & Burling LLP acted as its legal advisor. Centerview Partners LLC acted...
You must be a Standard 1 Year member to access this content.
Goodwin has advised AURELIUS Wachstumskapital on the financing of the acquisition of Windhoff Group. The Windhoff Group is an established, medium-sized IT service provider specializing in...
You must be a Standard 1 Year member to access this content.
Goodwin advised Isomorphic Labs on its strategic research collaboration with Novartis. Isomorphic Labs has signed a strategic research collaboration with Novartis to discover small molecule therapeutics against...
You must be a Standard 1 Year member to access this content.
Goodwin advised Burro on the round. Burro closed its $24 million Series B co-led by Catalyst Investors and Translink Capital. Existing investors S2G Ventures, Toyota Ventures, F-Prime...
You must be a Standard 1 Year member to access this content.
Cleary Gottlieb Steen & Hamilton is representing Synopsys, while Skadden and Goodwin Procter are representing ANSYS on the deal. Synopsys, Inc. (Synopsys) announced its acquisition of...
You must be a Standard 1 Year member to access this content.
Goodwin advised a consortium comprising Stirling Square, TA Associates and Macquarie Capital in its recommended public offer to acquire all shares in Byggfakta Group Nordic HoldCo...
You must be a Standard 1 Year member to access this content.
Goodwin advised Paindrainer AB on its commercial partnership agreement with Dr. Edward Rubin. Paindrainer AB announced a commercial partnership agreement with Dr. Edward Rubin, Past President of...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Kymera Therapeutics, Inc. on the offering, and Wilmer Cutler Pickering Hale and Dorr advised the underwriters. Kymera Therapeutics, Inc. (Nasdaq: KYMR) (“Kymera”) announced its...
You must be a Standard 1 Year member to access this content.
Goodwin advised Flagship Pioneering on the matter. Hogan Lovells acted for Omega Therapeutics, Inc. Novo Nordisk, Omega Therapeutics, Inc. (Nasdaq: OMGA) and Cellarity Inc. announced that Novo Nordisk...
You must be a Standard 1 Year member to access this content.
Lazard acted as TPI’s financial advisor. Goodwin Procter LLP acted as TPI’s legal advisor and Sullivan & Cromwell LLP acted as Oaktree’s legal advisor. TPI Composites,...
You must be a Standard 1 Year member to access this content.
